Low-Dose Naltrexone for Peripheral Neuropathy Pain: What the Research Actually Shows

If you live with burning, tingling, or shooting pain in your feet or hands, you’ve probably worked through the usual list: gabapentin, duloxetine, amitriptyline. Some people get real relief. Plenty get partial relief or side effects they can’t live with. So when someone mentions low-dose naltrexone (LDN), it’s fair to wonder if it deserves a place in the conversation. Here’s what the research shows, where it falls short, and what to ask your provider.

What Is Low-Dose Naltrexone?

Naltrexone is FDA-approved at 50 mg a day to prevent relapse in alcohol dependence. LDN is the same medication at roughly 1 to 5 mg a day. Using it for pain is off-label, and because there’s no FDA-approved low-dose product, it’s usually made by a compounding pharmacy.

How Might LDN Ease Nerve Pain?

Researchers are still working this out. The leading theory involves glial cells, the nervous system’s immune cells. In chronic nerve pain, glia can stay switched on and keep pain signals amplified. At low doses, naltrexone appears to reduce this glial inflammatory response through a receptor called TLR-4, and a brief, partial blockade of opioid receptors may increase the body’s own opioid signaling.

That’s a working hypothesis based on laboratory and early clinical research. However, this mechanism has not yet been confirmed in people with peripheral neuropathy. Learn more about why treating neuropathy matters

What the Research Shows for Neuropathy Pain

The strongest data so far is a 2021 randomized, double-blind trial in the Journal of Diabetes. Sixty-seven adults with painful diabetic neuropathy took either 2 mg of naltrexone or 10 mg of amitriptyline daily, with doses raised if pain fell by less than 20%. Over six weeks, the two drugs showed similar pain relief. Side effects were very different: 8 adverse events with naltrexone versus 52 with amitriptyline. Mild diarrhea was the most common complaint with LDN. Drowsiness was the most common with amitriptyline.

Smaller reports point in the same direction. One published case described a man with refractory diabetic neuropathy whose pain score dropped from 9 to 0.5 out of 10 within two weeks, with benefit still present at a two-year follow-up. In a pain clinic cohort of 70 patients taking 1 to 5 mg daily, 64% reported at least some relief, and responders were more likely to have neuropathic pain or complex regional pain syndrome.

Related conditions add context. A recent meta-analysis found LDN significantly reduced pain severity in fibromyalgia, another condition involving over-sensitive pain processing, though it had limited effect on pain thresholds.

Why Many Doctors Hesitate

Their caution isn’t unreasonable. The best neuropathy evidence is one trial of 67 people over six weeks, and it compared LDN with another drug rather than a placebo. Most other findings are case reports and uncontrolled studies. A recent narrative review called LDN safe and low-cost, with promise in neuropathic pain, but concluded the evidence doesn’t yet support routine use outside treatment-resistant cases.

“Not enough evidence” doesn’t mean “doesn’t work.” It means we don’t yet know how well it works, for whom, or at what dose. Larger placebo-controlled trials are what’s missing.

Side Effects and Safety

In the studies above, LDN was well tolerated. Vivid dreams were the main side effect reported against placebo in fibromyalgia trials, and mild diarrhea appeared in the diabetic neuropathy trial. Sleep changes and headaches are also commonly described.

One safety point matters a great deal: naltrexone blocks opioid medications. If you take any opioid, including codeine or tramadol products, tell your prescriber before starting. Combining them can trigger withdrawal and make your pain control fail.

Is LDN Worth Discussing With Your Provider?

It may be worth raising if your neuropathy hasn’t responded to standard medications, or you can’t tolerate them. It works best as part of a broader plan that also treats the cause, such as blood sugar control in diabetes or correcting vitamin deficiencies.

Questions to bring to your appointment:

• Is LDN appropriate given my other medications and health history?
• Which pharmacy will compound it, and what starting dose do you recommend?
• How long should we try it, and how will we judge whether it’s working?
• What’s the plan if it doesn’t help?

Frequently Asked Questions

Is low-dose naltrexone FDA-approved for neuropathy?

No. It’s prescribed off-label, which is legal and common, but it means the evidence base is smaller than for approved neuropathy drugs.

How long does LDN take to work?

The diabetic neuropathy trial measured results at six weeks. Timing varies from person to person, so your provider should agree to a trial period with you upfront.

Is LDN addictive?

Naltrexone isn’t an opioid and isn’t addictive. It works oppositely, by blocking opioid receptors.

What to avoid when taking low-dose naltrexone?

Avoid opioid pain medications, alcohol if advised by your doctor, and starting new medicines or supplements without checking with your healthcare provider. Never change your naltrexone dose on your own.

Have Questions About Managing Peripheral Neuropathy Pain?

Living with burning, tingling, or shooting nerve pain can affect your daily life. Understanding your options is an important step toward better pain management. OrthoWell Physical Therapy offers personalized care to help you explore supportive approaches for managing chronic pain and improving daily function.

Book Your Free 15-Minute Phone Consultation to discuss your concerns and learn more about our services.